Contributors to Volume PrefaceVolumes in SeriesSection I General Aspects 1. Pharmacological, Biochemical, and Molecular Biological Studies on Cytokine Receptors 2. Genetic Regulation and Activities of an Interleukin 1 Receptor Antagonist Protein 3. Identification of Intracellular Mediators of the Actions of Cytokines: Identifying Proteins Involved in Kinase Signaling Pathways 4. Measurement of Transport of Cytokines across the Blood-Brain BarrierSection II Anatomical Localization Studies 5. In Situ Hybridization Techniques for Localization of Interleukin 1 and Interleukin 1 Receptor Antagonist mRNA in Brain 6. Immunocytochemical Methods for Localization of Cytokines in Brain 7. Localization of Type I Interleukin 1 Receptor mRNA in Brain and Endocrine Tissues by in Situ Hybridization Histochemistry 8. Identification, Autoradiographic Localization, and Modulation of Interleukin 1 Receptors in Brain-Endocrine-Immune Axis: Methodology and Overview 9. c-fos-Based Functional Mapping of Central Pathways Subserving Effects of Interleukin 1 on the Hypothalamo-Pituitary-Adrenal Axis 10. Anatomical and Functional Approaches to Study of Interleukin 2 and Its Receptors in BrainSection III Neuroendocrine Actions 11. Endocrine Aspects of Neuroimmunomodulation: Methods and Overview 12. Determining Role and Sources of Endogenous Interleukin 1 in Pituitary-Adrenal Activation in Response to Stressful and Inflammatory Stimuli 13. In Vivo and in Vitro Methods for Studying Effects of Cytokines on Adrenocorticotropic Hormone, Arginine Vasopressin, and Oxytocin Secretion 14. In Vivo and in Vitro Models for Evaluating Effects of Interleukin 1 on Hypothalamic-Pituitary-Gonadal Axis 15. Methodological Evaluation of Sites and Mechanisms of Action Involved in Neuroendocrine Effects of Cytokines 16. In Vivo and in Vitro Methods for Studying Effects of Tumor Necrosis Factor on Pituitary Cells 17. Determination of Direct Effects of Cytokines on Release of Neuropeptides from Rat Hypothalamus by an in Vitro Method 18. Effects of Interleukin 1 on ß-Endorphin Secretion in AtT-20 Pituitary Cells: Methods and OverviewIndex
Contributors to Volume 16
Akira Arimura(15), U.S.–Japan Biomedical Research Laboratories, Tulane University Hebert Center, Belle Chasse, Louisiana 70037
William A Banks(4)
Veterans Affairs Medical Center, New Orleans, Louisiana 70146
Tulane University School of Medicine, New Orleans, Louisiana 70118
Alain Beaudet(10), Montreal Neurological Institute, Montréal, Québec, Canada H3A 2B4
Ann E. Berger(10), Cell Biology Research Upjohn, Kalamazoo, Michigan 49007
Frank Berkenbosch*(10), Departments of Pharmacology and Histology, Medical Faculty, Free University, 1081 BT Amsterdam, The Netherlands
Donald B. Carter, (2) CNS Research Upjohn, Kalamazoo, Michigan 49007
Alfredo Costa(17), Divisione di Neurologio C, Fondazione “Istituto Neurologico Casimiro Mondino,” 27100 Pavia, Italy
Emmett T. Cunningham, Jr.(7), Department of Ophthalmology, School of Medicine, University of California, San Francisco, San Francisco, California 94143
Errol B. De Souza(7, 8), Neurocrine Biosciences, Inc., La Jolla, California 92037
Steven K. Dower, (1) Department of Biochemistry, Immunex Research and Development Corporation, Seattle, Washington 98101
Osamu Ebisui(13), Second Division, Department of Internal Medicine, Kyoto University Faculty of Medicine, Kyoto 606, Japan
Anders Ericsson(9), Laboratory of Neuronal Structure and Function, The Salk Institute for Biological Studies, and The Foundation for Medical Research, La Jolla, California 92037
Gerald A. Evans(3), Biological Carcinogenesis and Development Program, PRI/DynCorp, Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, Maryland 21702
Mirela O. Fgărăsan(18), Department of Biochemistry and Molecular Biology, George Washington University Medical Center, Washington, D.C. 20037
William L. Farrar(3), Laboratory of Molecular Immunoregulation, Biological Response Modifiers Program, Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, Maryland 21702
Junichi Fukata(13), Second Division, Department of Internal Medicine, Kyoto University Faculty of Medicine, Kyoto 606, Japan
Philip W. Gold(5), Clinical Neuroendocrinology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892
M. Carmen Gonzalez(11), Universidad de La Laguna, Departamento de Fisiologia, E-38320 Tenerife, Spain
Paul E. Gottschall(15), Department of Pharmacology and Therapeutics, University of South Florida College of Medicine, Tampa, Florida 33612
Dimitri E. Grigoriadis(8), Central Nervous System Diseases Research, The DuPont Merck Pharmaceutical Company, Wilmington, Delaware 19880
Ashley Grossman(17), Department of Endocrinology, St. Bartholomew’s Hospital, London EC1A 7BE, England
Uwe Hanisch(10), Douglas Hospital Research Centre, and Departments of Psychiatry, Pharmacology and Therapeutics and of Neurology and Neurosurgery, Faculty of Medicine, McGill University, Montréal, Québec, Canada H4H 1R3
Hiroo Imura(13), Second Division, Department of Internal Medicine, Kyoto University Faculty of Medicine, Kyoto 606, Japan
Pushpa S. Kalra(14), Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, Florida 32610
Satya P. Kalra(14), Department of Obstetrics and Gynecology, University of Florida College of Medicine, Gainesville, Florida 32610
Sharada Karanth(11), Department of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75235
Abba J. Kastin(4)
Veterans Affairs Medical Center, New Orleans, Louisiana 70146
Tulane University School of Medicine, New Orleans, Louisiana 70118
Hiromasa Kobayashi(13), Second Division, Department of Internal Medicine, Kyoto University Faculty of Medicine, Kyoto 606, Japan
Marta Korbonits(17), Department of Endocrinology, St. Bartholomew’s Hospital, London EC1A 7BE, England
Júlio Licinio(5), Department of Psychiatry, Yale University School of Medicine, and Affective Disorders Program, West Haven Veterans Affairs Medical Center, West Haven, Connecticut 06516
Vittorio Locatelli(16), Department of Pharmacology, School of Medicine, University of Milan, 20129 Milan, Italy
Krzysztof Lyson(11), Department of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75235
Samuel M. McCann(11), Neuropeptide Division, Department of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75235
Ljiljana Milenkovic(11), Department of Obstetrics/Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California 94143
Norihiko Murakami(13), Second Division, Department of Internal Medicine, Kyoto University Faculty of Medicine, Kyoto 606, Japan
Yoshiyuki Naito(13), Department of Anesthesia, Kyoto University Faculty of Medicine, Kyoto 606, Japan
John A. Olschowka(6), Department of Neurobiology and Anatomy, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642
Alberto E. Panerai(16), Department of Pharmacology, School of Medicine, University of Milan, 20129 Milan, Italy
Rémi Quirion(10), Department of Psychiatry, McGill University, Douglas Hospital Research Centre, Verdun (Québec), Canada H4H 1R3
Valeria Rettori(11), Neuropeptide Division, Department of Physiology, University of Texas Southwestern Medical Center, Dallas, Texas 75235
Hallgeir Rui(3), Laboratory of Molecular Immunoregulation, Biological Response Modifiers Program, Frederick Cancer Research and Development Center, National Cancer Institute, Frederick, Maryland 21702
Paola Sacerdote(16), Department of Pharmacology, School of Medicine, University of Milan, 20129 Milan, Italy
Paul E. Sawchenko(9), Laboratory of Neuronal Structure and Function, The Salk Institute for Biological Studies, and The Foundation for Medical Research, La Jolla,...
